(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+) (BioDeep_00000896591)
代谢物信息卡片
(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)
化学式: C8H16N2O4Pt+2 (399.0758)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CCC(C(C1)N)N.C(=O)(C(=O)O)O.[Pt+2]
InChI: /q
描述信息
D000970 - Antineoplastic Agents
同义名列表
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Matthew Ng, Sylvia Chen, Whee Sze Ong, Akhila Balachander, Amanda Seet, Joe Yeong, Natalia Sutiman, Tony Kiat Hon Lim, Bernett Lee, Yu Amanda Guo, Wai Fook Leong, Sze Sing Lee, Justina Lam, Su Pin Choo, Anders Jacobsen Skanderup, Subhra Kumar Biswas, David Tai, Balram Chowbay. A phase 1b study of OXIRI in pancreatic adenocarcinoma patients and its immunomodulatory effects.
International journal of cancer.
2022 08; 151(3):435-449. doi:
10.1002/ijc.34021. [PMID: 35415893] - Eisuke Booka, Chiyo K Imamura, Masashi Takeuchi, Hirofumi Kawakubo, Hiroya Takeuchi, Yusuke Tanigawara, Yuko Kitagawa, Narikazu Boku. Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association.
2022 07; 25(4):770-782. doi:
10.1007/s10120-022-01291-z. [PMID: 35357635] - Ankita Tiwari, Devasish Bose, Pooja Mishra, Ankit Jain, Sanjay K Jain. Determination of Oxaliplatin and Curcumin in Combination via Micellar HPLC and Its Method Validation.
Journal of AOAC International.
2022 Jun; 105(4):999-1007. doi:
10.1093/jaoacint/qsac042. [PMID: 35353135] - Mingzhu Li, Zheng Li, Xiande Ma, Shengbo Jin, Yang Cao, Xuebing Wang, Jian Zhao, Jianbo Wang, Xin Wang, Jian Xu. Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway.
Aging.
2022 Jun; 14(12):5013-5022. doi:
10.18632/aging.203794. [PMID: 35759577] - Gunnar Folprecht, Anke Reinacher-Schick, Jürgen Weitz, Celine Lugnier, Anna-Lena Kraeft, Sarah Wisser, Daniela E Aust, Lukas Weiss, Nikolas von Bubnoff, Michael Kramer, Christian Thiede, Andrea Tannapfel. The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217).
Clinical colorectal cancer.
2022 06; 21(2):170-174. doi:
10.1016/j.clcc.2021.09.005. [PMID: 34772609] - Rhea Saad, Audra Hannun, Sally Temraz, Antoine Finianos, Rony M Zeenny. Oxaliplatin-induced thrombotic microangiopathy: a case report.
Journal of medical case reports.
2022 Mar; 16(1):110. doi:
10.1186/s13256-022-03309-7. [PMID: 35303936] - Dou Yang, Feng Chen, Dan Gong, Lei Zeng, Deng Xiang, Yuanqiao He, Leifeng Chen, Jinlong Yan, Shouhua Zhang. Establishment of childhood hepatoblastoma xenografts and evaluation of the anti-tumour effects of anlotinib, oxaliplatin and sorafenib.
Pediatric surgery international.
2022 Mar; 38(3):465-472. doi:
10.1007/s00383-021-05043-5. [PMID: 35032209] - Marjan Gholami, Azadeh Hekmat, Majid Khazaei, Majid Darroudi. OXA-CuS@UiO-66-NH2 as a drug delivery system for Oxaliplatin to colorectal cancer cells.
Journal of materials science. Materials in medicine.
2022 Feb; 33(3):26. doi:
10.1007/s10856-021-06574-y. [PMID: 35226206] - Zheng Wang, Yi Li, Rui Mao, Yu Zhang, Jun Wen, Qian Liu, Yanjun Liu, Tongtong Zhang. DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer.
Cell death & disease.
2022 02; 13(2):151. doi:
10.1038/s41419-022-04599-x. [PMID: 35165262] - Wenzhen Yuan, Xingpeng Xiao, Xuan Yu, Fuquan Xie, Pengya Feng, Kamran Malik, Jingyuan Wu, Ze Ye, Peng Zhang, Xiangkai Li. Probiotic Therapy (BIO-THREE) Mitigates Intestinal Microbial Imbalance and Intestinal Damage Caused by Oxaliplatin.
Probiotics and antimicrobial proteins.
2022 02; 14(1):60-71. doi:
10.1007/s12602-021-09795-3. [PMID: 33956306] - Taro Shibuki, Toshihiko Mizuta, Mototsugu Shimokawa, Futa Koga, Yujiro Ueda, Junichi Nakazawa, Azusa Komori, Satoshi Otsu, Shiho Arima, Masaru Fukahori, Akitaka Makiyama, Hiroki Taguchi, Takuya Honda, Kenji Mitsugi, Kenta Nio, Yasushi Ide, Norio Ureshino, Tsuyoshi Shirakawa, Taiga Otsuka. Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
BMC cancer.
2022 Jan; 22(1):19. doi:
10.1186/s12885-021-09139-y. [PMID: 34980029] - Wenen Zhou, Xueying Su, Lusheng Sun, Yanjun Liu, Zhenzhen Wang, Xiaoyu Wang, Yanhong Yang. Efficacy and safety of bevacizumab combined with chemotherapy in the treatment of advanced colorectal cancer and the effect on its adverse reactions.
Pakistan journal of pharmaceutical sciences.
2022 Jan; 35(1(Special)):381-386. doi:
. [PMID: 35236652] - Aerziguli Aierken, Ya-Kai Xie, Wenqi Dong, Abuliken Apaer, Jia-Jia Lin, Zihan Zhao, Shilong Yang, Zhen-Zhong Xu, Fan Yang. Rational Design of a Modality-Specific Inhibitor of TRPM8 Channel against Oxaliplatin-Induced Cold Allodynia.
Advanced science (Weinheim, Baden-Wurttemberg, Germany).
2021 11; 8(22):e2101717. doi:
10.1002/advs.202101717. [PMID: 34658162] - Marion Larroque, Carine Arnaudguilhem, Brice Bouyssiere, François Quenet, Nabila Bouazza, Marta Jarlier, Sonia Boulabas, Sandra Mounicou, Olivia Sgarbura. Evaluation of the environmental contamination and exposure risk in medical/non-medical staff after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy.
Toxicology and applied pharmacology.
2021 10; 429(?):115694. doi:
10.1016/j.taap.2021.115694. [PMID: 34428445] - Fleur van der Sijde, Marjolein Y V Homs, Marlies L van Bekkum, Thierry P P van den Bosch, Koop Bosscha, Marc G Besselink, Bert A Bonsing, Jan Willem B de Groot, Thomas M Karsten, Bas Groot Koerkamp, Brigitte C M Haberkorn, Saskia A C Luelmo, Leonie J M Mekenkamp, Dana A M Mustafa, Johanna W Wilmink, Casper H J van Eijck, Eveline E Vietsch, On Behalf Of The Dutch Pancreatic Cancer Group. Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
International journal of molecular sciences.
2021 Oct; 22(20):. doi:
10.3390/ijms222010902. [PMID: 34681562] - Atul Batra, Patricia A Tang, Winson Y Cheung. Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy.
American journal of clinical oncology.
2021 10; 44(10):519-525. doi:
10.1097/coc.0000000000000856. [PMID: 34366400] - Ketlyn P da Motta, Briana B Lemos, Jaini J Paltian, Angélica S Dos Reis, Gustavo B Blödorn, Diego Alves, Cristiane Luchese, Ethel A Wilhelm. 7-Chloro-4-(phenylselanyl) quinoline reduces renal oxidative stress induced by oxaliplatin in mice.
Canadian journal of physiology and pharmacology.
2021 Oct; 99(10):1102-1111. doi:
10.1139/cjpp-2021-0090. [PMID: 34015230] - Hitomi Fujishiro, Hiroki Taguchi, Satoko Hamao, Daigo Sumi, Seiichiro Himeno. Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules.
Toxicology in vitro : an international journal published in association with BIBRA.
2021 Sep; 75(?):105179. doi:
10.1016/j.tiv.2021.105179. [PMID: 33905841] - Stephen N Housley, Travis M Rotterman, Paul Nardelli, Dario I Carrasco, Richard K Noel, Laura O'Farrell, Timothy C Cope. Effects of route of administration on neural exposure to platinum-based chemotherapy treatment: a pharmacokinetic study in rat.
Neurotoxicology.
2021 09; 86(?):162-165. doi:
10.1016/j.neuro.2021.08.002. [PMID: 34363843] - Tao Ning, Jialu Li, Yi He, Haiyang Zhang, Xinyi Wang, Ting Deng, Rui Liu, Hongli Li, Ming Bai, Qian Fan, Kegan Zhu, Guoguang Ying, Yi Ba. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer.
Molecular therapy : the journal of the American Society of Gene Therapy.
2021 09; 29(9):2723-2736. doi:
10.1016/j.ymthe.2021.04.028. [PMID: 33905821] - Nan Zhang, Yafei Hao, Hansheng Liu, Qianqian Yu, Bi Bo, Jianwei Liang. Combined anti-cancer effects of curcumin and oxaliplatin on colon carcinoma colo205 cells using transplanted nude mice.
Pakistan journal of pharmaceutical sciences.
2021 Sep; 34(5(Special)):2021-2025. doi:
NULL. [PMID: 34862868] - R De Luca, C Volpe, O Mistretta, R Paci, G Ferrera, V Caputo, G Rosati, G Cicero. NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: a real-life study.
European review for medical and pharmacological sciences.
2021 08; 25(16):5310-5317. doi:
10.26355/eurrev_202108_26552. [PMID: 34486707] - Nikhil Biswas, Aiman Abu Ammar, Marina Frušić-Zlotkin, Naama Adi-Hen, Yonat Lehman-Katabi, Yael Levi-Kalisman, Taher Nassar, Simon Benita. Biodistribution and efficacy of the anticancer drug, oxaliplatin palmitate acetate, in mice.
International journal of pharmaceutics.
2021 Jul; 604(?):120740. doi:
10.1016/j.ijpharm.2021.120740. [PMID: 34062232] - Yaodong Yi, Liping Li, Feifeng Song, Ping Li, Mingyang Chen, Shixin Ni, Hengbin Zhang, Hui Zhou, Su Zeng, Huidi Jiang. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
Toxicology.
2021 07; 459(?):152853. doi:
10.1016/j.tox.2021.152853. [PMID: 34252480] - Huiya Wang, Xia Wang, Haiyang Zhang, Ting Deng, Rui Liu, Ying Liu, Hongli Li, Ming Bai, Tao Ning, Junyi Wang, Shaohua Ge, Yi Ba. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer.
Oncogene.
2021 07; 40(28):4695-4708. doi:
10.1038/s41388-021-01898-z. [PMID: 34140641] - A Taibi, M-L Perrin, J Albouys, J Jacques, C Yardin, S Durand-Fontanier, S M Bardet. 10 ns PEFs induce a histological response linked to cell death and cytotoxic T-lymphocytes in an immunocompetent mouse model of peritoneal metastasis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
2021 Jun; 23(6):1220-1237. doi:
10.1007/s12094-020-02525-1. [PMID: 33677709] - Yao He, Liuhui Fu, Yiping Li, Wenyan Wang, Mingli Gong, Jing Zhang, Xin Dong, Jiaoyan Huang, Quanbo Wang, Charles R Mackay, Yang-Xin Fu, Yun Chen, Xiaohuan Guo. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity.
Cell metabolism.
2021 05; 33(5):988-1000.e7. doi:
10.1016/j.cmet.2021.03.002. [PMID: 33761313] - Dazhou Xu, Zhimei Zhang, Shuxian Zhang, Xinjian Fang, Lei Wang, Qiuling Li. Efficacy of trastuzumab combined with SOX or IP chemotherapy regimen in the treatment of advanced gastric cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
2021 May; 26(3):932-939. doi:
. [PMID: 34268956] - Olivia Jones, Xiaoqian Cheng, Saravana R K Murthy, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Michael Keidar, Jerome Canady. The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro.
Scientific reports.
2021 04; 11(1):8967. doi:
10.1038/s41598-021-88451-w. [PMID: 33903679] - Seth Eisenberg, Kimberly Ito, Angela Rodriguez. Hazardous Drug Contamination: Presence of Bathroom Contamination in an Ambulatory Cancer Center.
Clinical journal of oncology nursing.
2021 Apr; 25(2):151-156. doi:
10.1188/21.cjon.151-156. [PMID: 33739338] - Briana B Lemos, Ketlyn P da Motta, Jaini J Paltian, Angélica S Reis, Gustavo B Blödorn, Mauro P Soares, Diego Alves, Cristiane Luchese, Ethel A Wilhelm. Role of 7-chloro-4-(phenylselanyl) quinoline in the treatment of oxaliplatin-induced hepatic toxicity in mice.
Canadian journal of physiology and pharmacology.
2021 Apr; 99(4):378-388. doi:
10.1139/cjpp-2020-0134. [PMID: 32810410] - Young Hoon Choi, Sang Hyub Lee, Min Su You, Bang Sup Shin, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Wooil Kwon, Jin-Young Jang, Sun-Whe Kim. Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX.
Gut and liver.
2021 Mar; 15(2):315-323. doi:
10.5009/gnl19182. [PMID: 32235008] - Mater H Mahnashi, Ashraf M Mahmoud, Khalid Alhazzani, A Z Alanazi, Ali Mohammed Alaseem, Mohammad M Algahtani, Mohamed M El-Wekil. Ultrasensitive and selective molecularly imprinted electrochemical oxaliplatin sensor based on a novel nitrogen-doped carbon nanotubes/Ag@cu MOF as a signal enhancer and reporter nanohybrid.
Mikrochimica acta.
2021 03; 188(4):124. doi:
10.1007/s00604-021-04781-6. [PMID: 33712895] - Jasmine Giani, Michael B Sawyer, Carole Chambers. Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
2021 Mar; 27(2):477-479. doi:
10.1177/1078155220934163. [PMID: 32588749] - Akitomo Yokokawa, Shun Kaneko, Sayuri Endo, Yuki Minowa, Hideaki Ayukawa, Ryohei Hirano, Fumio Nagashima, Daisuke Naruge, Naohiro Okano, Takaaki Kobayashi, Kirio Kawai, Junji Furuse, Takashi Furuta, Hiromi Shibasaki. Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.
European journal of drug metabolism and pharmacokinetics.
2021 Mar; 46(2):317-324. doi:
10.1007/s13318-021-00675-3. [PMID: 33619631] - B W Xie, L Zang, J J Ma, J Sun, X Yang, M L Wang, A G Lu, W G Hu, M H Zheng. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2021 Feb; 24(2):138-144. doi:
10.3760/cma.j.cn.441530-20200721-00433. [PMID: 33508919] - Y Tian, Q Wang, J Wang, X Y Qiao, J Zhang, Y C Lin, Y Li, L Q Fan, P G Yang, Q Zhao. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2021 Feb; 24(2):128-137. doi:
10.3760/cma.j.cn.441530-20201019-00565. [PMID: 33508918] - Ziyuan Wang, Xiaoting Sun, Yuanyuan Feng, Yang Wang, Lu Zhang, Yan Wang, Zhen Fang, Nisma Lena Bahaji Azami, Mingyu Sun, Qi Li. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Phytomedicine : international journal of phytotherapy and phytopharmacology.
2021 Feb; 82(?):153414. doi:
10.1016/j.phymed.2020.153414. [PMID: 33461143] - W J Koemans, R T van der Kaaij, E C E Wassenaar, C Grootscholten, H Boot, D Boerma, M Los, O Imhof, J H M Schellens, H Rosing, A D R Huitema, J W van Sandick. Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
2021 02; 47(2):486-489. doi:
10.1016/j.ejso.2020.07.037. [PMID: 32800401] - Motofumi Maruta, Takanori Miyoshi, Naomi Matsuo, Takuya Yamashina, Kenji Irie, Minako Tsuruta, Hiroko Tsukada, Moeko Tsuruyama, Masahisa Nagano, Yoichi Hiraki. Clinical pharmacokinetics of oxaliplatin in a hemodialysis patient with advanced gastric cancer.
Journal of chemotherapy (Florence, Italy).
2021 Feb; 33(1):51-55. doi:
10.1080/1120009x.2020.1728861. [PMID: 32066346] - Yi Hu, Chun Yang, Tania Amorim, Mohsin Maqbool, Jenny Lin, Chen Li, Chuanfeng Fang, Li Xue, Ariel Kwart, Hua Fang, Mei Yin, Allison J Janocha, Daisuke Tsuchimoto, Yusaku Nakabeppu, Xiaofeng Jiang, Alex Mejia-Garcia, Faiz Anwer, Jack Khouri, Xin Qi, Qing Y Zheng, Jennifer S Yu, Shan Yan, Thomas LaFramboise, Kenneth C Anderson, Leal C Herlitz, Nikhil C Munshi, Jianhong Lin, Jianjun Zhao. Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury.
Cancer research.
2021 02; 81(3):713-723. doi:
10.1158/0008-5472.can-20-1010. [PMID: 33288657] - Nihad Cheraga, Ammar Ouahab, Yan Shen, Ning-Ping Huang. Characterization and Pharmacokinetic Evaluation of Oxaliplatin Long-Circulating Liposomes.
BioMed research international.
2021; 2021(?):5949804. doi:
10.1155/2021/5949804. [PMID: 33987441] - Mahmoud Ashry, Doaa Galal El-Sahra, Dalia A Gaber, Mohamed A Mustafa, Khaled G Abdel-Wahhab. Nephroprotective Effect of Costus (Saussurea costus) Ethanolic Extract on Oxaliplatin®-induced Nephrotoxicity in Adult Male Wistar Rats.
Pakistan journal of biological sciences : PJBS.
2021 Jan; 24(8):830-839. doi:
10.3923/pjbs.2021.830.839. [PMID: 34486350] - Daxin Huang, Qingliang Lin, Jianyuan Song, Benhua Xu. Prognostic Value of Pretreatment Serum CA199 in Patients with Locally Advanced Rectal Cancer Treated with CRT Followed by TME with Normal Pretreatment Carcinoembryonic Antigen Levels.
Digestive surgery.
2021; 38(1):24-29. doi:
10.1159/000508442. [PMID: 33171467] - Szu-Jung Chen, Li-Hsien Chen, Yu-Min Yeh, Chou-Ching K Lin, Peng-Chan Lin, Han-Wei Huang, Meng-Ru Shen, Bo-Wen Lin, Jeng-Chang Lee, Cheng-Che Lee, Yueh-Feng Lee, Huai-Chueh Chiang, Jang-Yang Chang. Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.
Theranostics.
2021; 11(10):4672-4687. doi:
10.7150/thno.54793. [PMID: 33754020] - Robin J Lurvink, Rudaba Tajzai, Koen P Rovers, Emma C E Wassenaar, Dirk-Jan A R Moes, Giulia Pluimakers, Djamila Boerma, Jacobus W A Burger, Simon W Nienhuijs, Ignace H J T de Hingh, Maarten J Deenen. Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial.
Annals of surgical oncology.
2021 Jan; 28(1):265-272. doi:
10.1245/s10434-020-08743-9. [PMID: 32572849] - Amira Mohamed Abdelhamid, Shireen Sami Mahmoud, Aziza E Abdelrahman, Nelly Mohamed Said, Mostafa Toam, Walaa Samy, Marwa AbdEl-Moniem Amer. Protective effect of cerium oxide nanoparticles on cisplatin and oxaliplatin primary toxicities in male albino rats.
Naunyn-Schmiedeberg's archives of pharmacology.
2020 12; 393(12):2411-2425. doi:
10.1007/s00210-020-01946-7. [PMID: 32710137] - Frédéric Dumont, Christophe Passot, Jean-Luc Raoul, Vahan Kepenekian, Bénédicte Lelièvre, Michelle Boisdron-Celle, Sandrine Hiret, Hélène Senellart, Francois Pein, Audrey Blanc-Lapierre, Judith Raimbourg, Emilie Thibaudeau, Olivier Glehen. A phase I dose-escalation study of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers.
European journal of cancer (Oxford, England : 1990).
2020 11; 140(?):37-44. doi:
10.1016/j.ejca.2020.09.010. [PMID: 33039812] - Alessandro Di Federico, Giacomo Nuvola, Monia Sisi, Barbara Lenzi, Elisabetta Nobili, Davide Campana. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?.
Anti-cancer drugs.
2020 11; 31(10):1103-1105. doi:
10.1097/cad.0000000000000987. [PMID: 32826413] - Nilgun Yildirim, Mahir Cengiz. Predictive clinical factors of chronic peripheral neuropathy induced by oxaliplatin.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.
2020 Oct; 28(10):4781-4788. doi:
10.1007/s00520-020-05319-x. [PMID: 31974772] - H Luo, L Liu, J-J Zhao, X-F Mi, Q-J Wang, M Yu. Effects of oxaliplatin on inflammation and intestinal floras in rats with colorectal cancer.
European review for medical and pharmacological sciences.
2020 10; 24(20):10542-10549. doi:
10.26355/eurrev_202010_23407. [PMID: 33155210] - Sarah Schoch, Sabine Gajewski, Jana Rothfuß, Andrea Hartwig, Beate Köberle. Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics.
International journal of molecular sciences.
2020 Sep; 21(18):. doi:
10.3390/ijms21186928. [PMID: 32967255] - Yukako Ito, Shinji Kobuchi, Mako Takeda, Miki Morimoto. Effect of intact oxaliplatin in plasma on a cold allodynia after multiple administrations in colorectal cancer model rats.
Annals of palliative medicine.
2020 Sep; 9(5):3000-3006. doi:
10.21037/apm-20-542. [PMID: 32692214] - K Pang, J Song, Z Bai, Z Zhang. miR-15a-5p targets PHLPP2 in gastric cancer cells to modulate platinum resistance and is a suitable serum biomarker for oxaliplatin resistance.
Neoplasma.
2020 Sep; 67(5):1114-1121. doi:
10.4149/neo_2020_190904n861. [PMID: 32567934] - Javier Sastre, Virginia de la Orden, Antonio Martínez, Inmaculada Bando, Milagros Balbín, Beatriz Bellosillo, Sarai Palanca, Maria Isabel Peligros Gomez, Beatriz Mediero, Patricia Llovet, Virginia Moreno Moral, José Maria Viéitez, Pilar García-Alfonso, Silvia Gil Calle, Maria José Ortiz-Morales, Antonieta Salud, Guillermo Quintero, Carlos Lopez, Eduardo Díaz-Rubio, Enrique Aranda. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.
Clinical colorectal cancer.
2020 09; 19(3):e110-e116. doi:
10.1016/j.clcc.2020.02.014. [PMID: 32278676] - S J Schraa, K L van Rooijen, D E W van der Kruijssen, C Rubio Alarcón, J Phallen, M Sausen, J Simmons, V M H Coupé, W M U van Grevenstein, S Elias, H M Verkooijen, M M Laclé, L J W Bosch, D van den Broek, G A Meijer, V E Velculescu, R J A Fijneman, G R Vink, M Koopman. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
BMC cancer.
2020 Aug; 20(1):790. doi:
10.1186/s12885-020-07252-y. [PMID: 32819390] - Changhoon Yoo, Sang Soo Lee, Ki Byung Song, Jae Ho Jeong, Jaewon Hyung, Do Hyun Park, Tae Jun Song, Dong Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Seung Soo Lee, Jin Hee Kim, Hyung-Seung Jin, Jin-Hong Park, Dae Wook Hwang, Jae Hoon Lee, Woohyung Lee, Heung-Moon Chang, Kyu-Pyo Kim, Baek-Yeol Ryoo, Song Cheol Kim. Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
British journal of cancer.
2020 08; 123(3):362-368. doi:
10.1038/s41416-020-0867-x. [PMID: 32433600] - Rory Mitchell, Marta Mikolajczak, Christian Kersten, Sue Fleetwood-Walker. ErbB1-dependent signalling and vesicular trafficking in primary afferent nociceptors associated with hypersensitivity in neuropathic pain.
Neurobiology of disease.
2020 08; 142(?):104961. doi:
10.1016/j.nbd.2020.104961. [PMID: 32531343] - Carole Lacout, Corentin Orvain, Valérie Seegers, Manon De Vries, Mélanie Mercier, Jonathan Farhi, Aline Clavert, Sylvain Thepot, Marie-Pierre Moles, Norbert Ifrah, Mathilde Hunault-Berger, Aline Tanguy-Schmidt. R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory study.
European journal of haematology.
2020 Aug; 105(2):223-230. doi:
10.1111/ejh.13429. [PMID: 32302426] - Peng Liu, Liwei Zhao, Gladys Ferrere, Carolina Alves-Costa-Silva, Pierre Ly, Qi Wu, Ai-Ling Tian, Lisa Derosa, Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses.
Oncoimmunology.
2020 07; 9(1):1789284. doi:
10.1080/2162402x.2020.1789284. [PMID: 32923151] - Loek A W de Jong, Fortuné M K Elekonawo, Marie Lambert, Jan Marie de Gooyer, Henk M W Verheul, David M Burger, Johannes H W de Wilt, Etienne Chatelut, Rob Ter Heine, Philip R de Reuver, Andre J A Bremers, Nielka P van Erp. Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study.
Cancer chemotherapy and pharmacology.
2020 07; 86(1):141-150. doi:
10.1007/s00280-020-04107-y. [PMID: 32594200] - Shawna Klahn, Nikolaos Dervisis, Daniel L Gustafson, Jonathan Abbott. Dose-Escalation and Pharmacokinetic Study Following a Single Dose of Oxaliplatin in Cancer-Bearing Dogs.
Journal of the American Animal Hospital Association.
2020 Jul; 56(4):206-214. doi:
10.5326/jaaha-ms-7007. [PMID: 32412339] - Radu Vidra, Raluca Bodea, Voicu Mercea, Adina Nemes. Challenges of pancreatic cancer chemotherapy in the COVID-19 era.
Journal of gastrointestinal and liver diseases : JGLD.
2020 06; 29(2):273-275. doi:
10.15403/jgld-2527. [PMID: 32531001] - Natsumi Matsumoto, Yutaro Kubota, Hiroo Ishida, Masae Sekido, Ryotaro Ohkuma, Tomoyuki Ishiguro, Yuya Hirasawa, Hirotsugu Ariizumi, Takuya Tsunoda, Toshikazu Ikusue, Kouji Kobayashi, Atsushi Hisamatsu, Hirokazu Toshima, Ken Shimada, Ken-Ichi Fujita. Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients.
Cancer chemotherapy and pharmacology.
2020 06; 85(6):1119-1128. doi:
10.1007/s00280-020-04087-z. [PMID: 32458030] - L Sun, Y Xu, T Zhang, Y Yang. Impact of the COVID-19 outbreak on adjuvant chemotherapy for patients with stage II or III colon cancer: experiences from a multicentre clinical trial in China.
Current oncology (Toronto, Ont.).
2020 06; 27(3):159-162. doi:
10.3747/co.27.6529. [PMID: 32669926] - Laura L Meijer, Ingrid Garajová, Chiara Caparello, Tessa Y S Le Large, Adam E Frampton, Enrico Vasile, Niccola Funel, Geert Kazemier, Elisa Giovannetti. Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.
Annals of surgery.
2020 06; 271(6):1137-1147. doi:
10.1097/sla.0000000000003084. [PMID: 30394883] - Lidia S Foteeva, Olga V Kuznetsova, Bernhard K Keppler. How versatile is the use of ultrafiltration to study biointeractions of therapeutic metallodrugs?.
Analytical biochemistry.
2020 06; 598(?):113697. doi:
10.1016/j.ab.2020.113697. [PMID: 32224145] - Su-Hyun Kim, Moon Ki Choi, Na Young Park, Jae-Won Hyun, Min Young Lee, Ho Jin Kim, Su Kyung Jung, Yongjun Cha. Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy.
Scientific reports.
2020 05; 10(1):7995. doi:
10.1038/s41598-020-64511-5. [PMID: 32409710] - Dario Baratti, Paolo Sammartino, Shigeki Kusamura, Marcello Deraco, Luca Ansaloni, Salvatore Asero, Gianluca Baiocchi, Pietro Bagnoli, Davide Cavaliere, Massimo Framarini, Roberto Cirocchi, Federico Coccolini, Franco Decian, Paolo Delrio, Cinzia Sassaroli, Michele De Simone, Manuela Robella, Marco Vaira, Andrea Di Giorgio, Anna Fagotti, Domenica Lorusso, Orietta Federici, Giammaria Fiorentini, Massimiliano Fambrini, Stefano Scaringi, Alfredo Garofalo, Mario Valle, Roberta Gelmini, Francesca Cabry, Nicola Cautero, Lorena Sorrentino, Luigina Graziosi, Marcello Guaglio, Matteo Montenovo, Valentina Bartolini, Piero Vincenzo Lippolis, Antonio Macrì, Enrico Maria Pasqual, Francesco Roviello, Daniele Marrelli, Elena Orsenigo, Antonio Sommariva. Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
2020 05; 46(5):737-739. doi:
10.1016/j.ejso.2020.02.010. [PMID: 32107093] - Ping Cheng, Huan Liu, Yinchuan Li, Peiling Pi, Yu Jiang, Shaozhen Zang, Xiaorong Li, Ailing Fu, Xiaoyuan Ren, Jianqiang Xu, Arne Holmgren, Jun Lu. Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury.
Biochemical pharmacology.
2020 05; 175(?):113873. doi:
10.1016/j.bcp.2020.113873. [PMID: 32092292] - Maike Zimmermann, Tao Li, Thomas J Semrad, Chun-Yi Wu, Aiming Yu, George Cimino, Michael Malfatti, Kurt Haack, Kenneth W Turteltaub, Chong-Xian Pan, May Cho, Edward J Kim, Paul T Henderson. Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy.
Molecular cancer therapeutics.
2020 04; 19(4):1070-1079. doi:
10.1158/1535-7163.mct-19-0133. [PMID: 32029633] - Ziyuan Wang, Yueping Zhan, Jian Xu, Yang Wang, Mingyu Sun, Jia Chen, Tingyu Liang, Lili Wu, Ke Xu. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Journal of agricultural and food chemistry.
2020 Mar; 68(12):3850-3858. doi:
10.1021/acs.jafc.0c00107. [PMID: 32167760] - Simer J Bains, Hanna Abrahamsson, Kjersti Flatmark, Svein Dueland, Knut H Hole, Therese Seierstad, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree. Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer.
Cancer immunology, immunotherapy : CII.
2020 Mar; 69(3):355-364. doi:
10.1007/s00262-019-02458-x. [PMID: 31893287] - Celia Rousseau, Tan Ngoc Nguyen, Jean Michel Rebibou, Jean Noel Bastie, Sylvain Audia, Ariane Darut-Jouve, Mathieu Legendre. Oxaliplatin-Induced Evans Syndrome: A Possible Dual Mechanism.
Clinical colorectal cancer.
2020 03; 19(1):57-60. doi:
10.1016/j.clcc.2019.11.001. [PMID: 31883972] - Lars H Jensen, Rikke Fredslund Andersen, Lene Byriel, Eva Fernebro, Anders Jakobsen, Jan Lindebjerg, Lise Nottelmann, John Ploen, Torben F Hansen. Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers.
Acta oncologica (Stockholm, Sweden).
2020 Mar; 59(3):298-301. doi:
10.1080/0284186x.2019.1701201. [PMID: 31838939] - Xiumei Wang, Yongqiang Liu, Qiong Qin, Ti Zheng. Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.
Bioscience reports.
2020 02; 40(2):. doi:
10.1042/bsr20200071. [PMID: 32039450] - Kentaro Yamazaki, Shigemi Matsumoto, Chiyo K Imamura, Chiemi Yamagiwa, Ayaka Shimizu, Takayuki Yoshino. Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.
Japanese journal of clinical oncology.
2020 Feb; 50(2):122-128. doi:
10.1093/jjco/hyz149. [PMID: 31665356] - Paula Zaręba, Beata Gryzło, Katarzyna Malawska, Kinga Sałat, Georg C Höfner, Alicja Nowaczyk, Łukasz Fijałkowski, Anna Rapacz, Adrian Podkowa, Anna Furgała, Paweł Żmudzki, Klaus T Wanner, Barbara Malawska, Katarzyna Kulig. Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.
European journal of medicinal chemistry.
2020 Feb; 188(?):111920. doi:
10.1016/j.ejmech.2019.111920. [PMID: 31901745] - Caigui Lin, Jiyang Dong, Zhiliang Wei, Kian-Kai Cheng, Jie Li, Song You, Yueyue Liu, Xiaomin Wang, Zhong Chen. 1H NMR-Based Metabolic Profiles Delineate the Anticancer Effect of Vitamin C and Oxaliplatin on Hepatocellular Carcinoma Cells.
Journal of proteome research.
2020 02; 19(2):781-793. doi:
10.1021/acs.jproteome.9b00635. [PMID: 31916767] - Shinji Kobuchi, Yosuke Katsuyama, Yukako Ito. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats.
Xenobiotica; the fate of foreign compounds in biological systems.
2020 Feb; 50(2):223-230. doi:
10.1080/00498254.2019.1601790. [PMID: 30938550] - Young-Woong Won, Hyewon Lee, Hyeon-Seok Eom, Jin Seok Kim, Cheolwon Suh, Dok Hyun Yoon, Jung Yong Hong, Hye Jin Kang, Jae Hoon Lee, Won Seog Kim, Seok Jin Kim, Won-Sik Lee, Myung Hee Chang, Young Rok Do, Jun Ho Yi, Inho Kim, Jong-Ho Won, Kyoungha Kim, Sung Yong Oh, Jae-Cheol Jo. A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Annals of hematology.
2020 Feb; 99(2):255-264. doi:
10.1007/s00277-019-03891-9. [PMID: 31897676] - Yunpeng Zhang, Atsushi Yonezawa, Shunsaku Nakagawa, Satoshi Imai, Masaya Denda, Tomohiro Omura, Takayuki Nakagawa, Kazuo Matsubara. Cisplatin, rather than oxaliplatin, increases paracellular permeability of LLC-PK1 cells via activating protein kinase C.
Drug metabolism and pharmacokinetics.
2020 Feb; 35(1):111-116. doi:
10.1016/j.dmpk.2019.09.001. [PMID: 31964622] - Eric Van Cutsem, Caroline Paccard, Marielle Chiron, Josep Tabernero. Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2020 02; 26(3):717-725. doi:
10.1158/1078-0432.ccr-19-1985. [PMID: 31727675] - Vahid Ziaaddini, Maryam Saeidifar, Mahboubeh Eslami-Moghadam, Mandana Saberi, Masoud Mozafari. Improvement of efficacy and decrement cytotoxicity of oxaliplatin anticancer drug using bovine serum albumin nanoparticles: synthesis, characterisation and release behaviour.
IET nanobiotechnology.
2020 Feb; 14(1):105-111. doi:
10.1049/iet-nbt.2019.0086. [PMID: 31935686] - Jia Gang Han, Zhen Jun Wang, Wei Gen Zeng, Yan Bin Wang, Guang Hui Wei, Zhi Wei Zhai, Bao Cheng Zhao, Bing Qiang Yi. Efficacy and safety of self-expanding metallic stent placement followed by neoadjuvant chemotherapy and scheduled surgery for treatment of obstructing left-sided colonic cancer.
BMC cancer.
2020 Jan; 20(1):57. doi:
10.1186/s12885-020-6560-x. [PMID: 31992260] - Sonali G Thorat, Rupesh V Chikhale, Madhukar R Tajne. Development and Validation of HPLC and HPTLC Methods for Therapeutic Drug Monitoring of Capecitabine in Colorectal Cancer Patients.
Journal of chromatographic science.
2020 Jan; 57(10):892-900. doi:
10.1093/chromsci/bmz067. [PMID: 31609432] - Daichi Watanabe, Hironori Fujii, Yunami Yamada, Hirotoshi Iihara, Takuma Ishihara, Nobuhisa Matsuhashi, Takao Takahashi, Kazuhiro Yoshida, Akio Suzuki. Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin.
Anticancer research.
2020 Jan; 40(1):299-304. doi:
10.21873/anticanres.13953. [PMID: 31892580] - Hyunkyung Park, Ju-Hee Bang, Ah-Rong Nam, Ji Eun Park, Mei Hua Jin, Yung-Jue Bang, Do-Youn Oh. The prognostic role of soluble TGF-beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.
Cancer medicine.
2020 01; 9(1):43-51. doi:
10.1002/cam4.2677. [PMID: 31701645] - Matilda Holm, Emma Andersson, Emerik Osterlund, Ali Ovissi, Leena-Maija Soveri, Anna-Kaisa Anttonen, Soili Kytölä, Kristiina Aittomäki, Pia Osterlund, Ari Ristimäki. Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing.
PloS one.
2020; 15(11):e0239819. doi:
10.1371/journal.pone.0239819. [PMID: 33237900] - Katherine Stockstill, Carrie Wahlman, Kathryn Braden, Zhoumou Chen, Gina L Yosten, Dilip K Tosh, Kenneth A Jacobson, Timothy M Doyle, Willis K Samson, Daniela Salvemini. Sexually dimorphic therapeutic response in bortezomib-induced neuropathic pain reveals altered pain physiology in female rodents.
Pain.
2020 01; 161(1):177-184. doi:
10.1097/j.pain.0000000000001697. [PMID: 31490328] - Kaleem Ullah, Shujaat Ali Khan, Muhammad Sohail, Abdul Mannan, Ghulam Murtaza. Pharmacokinetic Profile of Oxaliplatin-Loaded pH-Responsive Hydrogels in Rabbits.
Current pharmaceutical design.
2020; 26(44):5755-5763. doi:
10.2174/1381612826666200813125159. [PMID: 32787758] - Lu Chen, Zeyang Wang, Qingwen Xu, Yuxi Liu, Le Chen, Suhang Guo, Hua Wang, Kui Zeng, Junqing Liu, Su Zeng, Lushan Yu. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Theranostics.
2020; 10(8):3562-3578. doi:
10.7150/thno.39944. [PMID: 32206108] - Tadashi Yokoyama, Hiroshi Makino, Atsushi Hirakata, Junji Ueda, Hideyuki Takata, Mikihiro Okusa, Manpei Kawashima, Takeshi Tsujino, Masaru Hosone, Akira Matsushita, Yoshiharu Nakamura, Hiroshi Yoshida. Conversion Surgery for Metastatic Pancreatic Mucinous Carcinoma Responsive to Systemic Chemotherapy with Modified FOLFIRINOX: A Case Report.
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.
2019 Dec; 86(5):284-290. doi:
10.1272/jnms.jnms.2019_86-502. [PMID: 31105119] - Yanshuo Cao, Qing Chang, Wenjiang Zhang, Olga Ornatsky, David Hedley, Eric X Chen. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Cancer chemotherapy and pharmacology.
2019 Dec; 84(6):1195-1200. doi:
10.1007/s00280-019-03956-6. [PMID: 31520102] - Andrea Šebestová, Daniel Baron, Radka Pechancová, Tomáš Pluháček, Jan Petr. Determination of oxaliplatin enantiomers at attomolar levels by capillary electrophoresis connected with inductively coupled plasma mass spectrometry.
Talanta.
2019 Dec; 205(?):120151. doi:
10.1016/j.talanta.2019.120151. [PMID: 31450399] - Danping Wang, Xiaofei Li, Lingyan Xu, Wentong Fang, Xiaomin Cai, Ying Wang, Jiawei Wang, Yuanyuan Wang, Fengjiao Zhao, Yanhong Gu. Dose-escalation of oxaliplatin in hemodialysis patient treated with FOLFOX therapy: A case report.
Medicine.
2019 Nov; 98(44):e17462. doi:
10.1097/md.0000000000017462. [PMID: 31689749] - Maho Tsubota, Ryotaro Fukuda, Yusuke Hayashi, Takaya Miyazaki, Shin Ueda, Rika Yamashita, Nene Koike, Fumiko Sekiguchi, Hidenori Wake, Shuji Wakatsuki, Yuka Ujiie, Toshiyuki Araki, Masahiro Nishibori, Atsufumi Kawabata. Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants.
Journal of neuroinflammation.
2019 Oct; 16(1):199. doi:
10.1186/s12974-019-1581-6. [PMID: 31666085] - Luis Galvez, Mate Rusz, Michaela Schwaiger-Haber, Yasin El Abiead, Gerrit Hermann, Ute Jungwirth, Walter Berger, Bernhard K Keppler, Michael A Jakupec, Gunda Koellensperger. Preclinical studies on metal based anticancer drugs as enabled by integrated metallomics and metabolomics.
Metallomics : integrated biometal science.
2019 10; 11(10):1716-1728. doi:
10.1039/c9mt00141g. [PMID: 31497817] - Xin Shelley Wang, Qiuling Shi, Nishin A Bhadkamkar, Charles S Cleeland, Araceli Garcia-Gonzalez, Jonathan R Aguilar, Cobi Heijnen, Cathy Eng. Minocycline for Symptom Reduction During Oxaliplatin-Based Chemotherapy for Colorectal Cancer: A Phase II Randomized Clinical Trial.
Journal of pain and symptom management.
2019 10; 58(4):662-671. doi:
10.1016/j.jpainsymman.2019.06.018. [PMID: 31254639]
